Fidelity NorthStar® Fund

Investment Strategy

An open mandate with a focus on the best investment ideas
Fidelity NorthStar® Fund has an open mandate to seek the best ideas wherever they may lie, based on the convictions of veteran managers.

Performance

Performance for this series is not available at this time.

Performance

Annual compound performance – as at 31-Jul-2017

PERIOD Fund
1 month -2.43% 4
3 month -5.60% 4
6 month 1.49% 4
1 year 0.26% 4
2 year 0.23% 4
3 year 7.66% 3
5 year 16.70% 2
7 year 11.89%
10 year 5.65% 2
YTD -0.64% 4
Since Inception 7.63%

Calendar year performance – as at 31-Jul-2017

Calendar year performance – as at 31-Jul-2017

Growth of $10,000 since inception³ – as at 31-Jul-2017

Growth of $10,000 since inception³ – as at 31-Jul-2017
Fund risk measures – as at 31-Jul-2017
  Fund
Annual Standard Deviation 8.93

Risk measures are based on 3-year net returns (series B). (All returns are calculated in Canadian currency.)  R2 and Beta are not available for this fund as it is not managed to a specific benchmark.

Volatility meter

Medium

A fund’s volatility is determined using a statistical measure called “standard deviation". Standard deviation measures the amount of variability of returns that has historically occurred relative to the average return. The higher the standard deviation of a fund, the greater the range of returns it has experienced in the past. Other types of risk, both measurable and non-measurable, exist. In addition, just as historical performance may not be indicative of future returns, a fund’s historical volatility may not be indicative of its future volatility.

PM - Joel Tillinghast- Lessons learned over a thirty year - EN
Lipper Awards 2016

Fund facts

NAVPU – Series B

$27.26 – as at 18-Aug-2017

NAVPU – Series B

$21.67 – as at 18-Aug-2017

Series inception date

31-Oct-2002

31-Oct-2002

Fund benchmark

None

Fund aggregate assets (all series)

$9.160 billion
as at 31-Jul-2017

Management expense ratio - Series B

2.34% – as at 30-Sep-2016

 
Quarterly Top Ten Holdings
Anthem  
Seria Co.  
Gilead Sciences  
Ottogi  
Teva Pharmaceutical  
Bed Bath & Beyond  
Hon Hai Precision  
Hyundai Mobis  
Deckers Outdoor  
Amgen  
Total number of holdings 666
Top 10 holdings aggregate 18.8%
Allocation to funds

Asset Mix
as at 30-Jun-2017

  Current monthLast monthTwo months ago
Foreign Equities 59.8%59.0%61.0%
Other Investments 0.4%0.4%0.4%
Cash & Other 39.8%40.7%38.6%

Top historical sector mix (%)
as at 30-Jun-2017

Consumer Discretionary 16.2%16.3%17.9%
Health Care 14.3%13.6%14.5%
Consumer Staples 7.8%9.4%8.8%
Information Technology 6.8%5.7%5.8%
Industrials 5.9%5.7%5.5%
Financials 3.6%3.3%3.7%
Materials 2.4%1.9%1.9%
Energy 1.8%1.9%1.8%

Country mix (%)
as at 30-Jun-2017

United States 59.5%60.1%61.3%
Japan 12.6%12.7%12.5%
South Korea 6.4%7.1%6.3%
Taiwan 2.7%2.6%2.5%
Hong Kong 2.5%2.4%2.5%
Israel 2.5%1.8%2.0%
Netherlands 2.2%1.7%1.6%
Australia 1.5%1.5%1.5%
India 1.5%1.4%1.5%
France 1.3%
United Kingdom 1.3%1.3%
702766.69.0